Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis

References

• Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011;10:75–82.
   PubMed Web of Science ®Google Scholar
• Ioannides ZA, Ngo ST, Henderson RD, McCombe PA, Steyn FJ. Altered metabolic homeostasis in amyotrophic lateral sclerosis: mechanisms of energy imbalance and contribution to disease progression. Neurodegener Dis. 2016;16:382–97.
   PubMed Web of Science ®Google Scholar
• O'Reilly EJ, Wang H, Weisskopf MG, Fitzgerald KC, Falcone G, McCullough ML, et al. Premorbid body mass index and risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:205–11.
   PubMed Web of Science ®Google Scholar
• Scarmeas N, Shih T, Stern Y, Ottman R, Rowland LP. Premorbid weight, body mass, and varsity athletics in ALS. Neurology. 2002;59:773–5.
   PubMed Web of Science ®Google Scholar
• Peter RS, Rosenbohm A, Dupuis L, Brehme T, Kassubek J, Rothenbacher D, et al. Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia. Eur J Epidemiol. 2017;32:901–8.
   PubMed Web of Science ®Google Scholar
• Marin B, Desport JC, Kajeu P, Jesus P, Nicolaud B, Nicol M, et al. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry. 2011;82:628–34.
   PubMed Web of Science ®Google Scholar
• Clavelou P, Blanquet M, Peyrol F, Ouchchane L, Gerbaud L. Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient result of a French multicentre cohort survey. J Neurol Sci. 2013;331:126–31.
   PubMed Web of Science ®Google Scholar
• Desport JC, Preux PM, Truong CT, Courat L, Vallat JM, Couratier P. Nutritional assessment and survival in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:91–6.
   PubMed Web of Science ®Google Scholar
• Fasano A, Fini N, Ferraro D, Ferri L, Vinceti M, Errals, et al. Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study. Amyotroph Lat Scl Frontotemporal Degener. 2017;18:233–42.
   PubMed Web of Science ®Google Scholar
• Jawaid A, Murthy SB, Wilson AM, Qureshi SU, Amro MJ, Wheaton M, et al. A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotroph Lateral Scler. 2010;11:542–8.
   PubMed Web of Science ®Google Scholar
• Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM. Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle Nerve. 2011;44:20–4.
   PubMed Web of Science ®Google Scholar
• Roubeau V, Blasco H, Maillot F, Corcia P, Praline J. Nutritional assessment of amyotrophic lateral sclerosis in routine practice: value of weighing and bioelectrical impedance analysis. Muscle Nerve. 2015;51:479–84.
   PubMed Web of Science ®Google Scholar
• Stambler N, Charatan M, Cedarbaum JM, ALS CNTF Treatment Study Group. Prognostic indicators of survival in ALS. Neurology. 1998;50:66–72.
   PubMed Web of Science ®Google Scholar
• Wolf J, Safer A, Wöhrle JC, Palm F, Nix WA, Maschke M, et al. Factors predicting survival in ALS patients - data from a population-based registry in Rhineland-Palatinate, Germany. Neuroepidemiology. 2015;44:149–55.
   PubMed Web of Science ®Google Scholar
• Gallo V, Wark PA, Jenab M, Pearce N, Brayne C, Vermeulen R, et al. Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort. Neurology. 2013;80:829–38.
   PubMed Web of Science ®Google Scholar
• Calvo A, Moglia C, Lunetta C, Marinou K, Ticozzi N, Ferrante GD, et al. Factors predicting survival in ALS: a multicenter Italian study. J Neurol. 2017;264:54–63.
   PubMed Web of Science ®Google Scholar
• Mariosa D, Beard JD, Umbach DM, Bellocco R, Keller J, Peters TL, et al. Body mass index and amyotrophic lateral sclerosis: a study of US military veterans. Am J Epidemiol.2017;185:362–71.
   PubMed Web of Science ®Google Scholar
• Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, et al. Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol. 2009;256:1236–42.
   PubMed Web of Science ®Google Scholar
• Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufrere B, et al. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr. 2001;74:328–34.
   PubMed Web of Science ®Google Scholar
• Desport JC, Torny F, Lacoste M, Preux PM, Couratier P. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegener Dis. 2005;2:202–7.
   PubMed Web of Science ®Google Scholar
• Funalot B, Desport JC, Sturtz F, Camu W, Couratier P. High metabolic level in patients with familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:113–7.
   PubMed Web of Science ®Google Scholar
• Jesus P, Fayemendy P, Nicol M, Lautrette G, Sourisseau H, Preux PM, et al. Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2018;25:97–104.
   PubMed Web of Science ®Google Scholar
• Kasarskis EJ, Berryman S, Vanderleest JG, Schneider AR, McClain CJ. Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr. 1996;63:130–7.
   PubMed Web of Science ®Google Scholar
• Shimizu T, Hayashi H, Tanabe H. Energy metabolism of ALS patients under mechanical ventilation and tube feeding. Rinsho Shinkeigaku. 1991;31:255–9.
   PubMedGoogle Scholar
• Vaisman N, Lusaus M, Nefussy B, Niv E, Comaneshter D, Hallack R, et al. Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs? J Neurol Sci. 2009;279:26–9.
   PubMed Web of Science ®Google Scholar
• Steyn FJ, Ioannides ZA, van Eijk RPA, Heggie S, Thorpe KA, Ceslis A, et al. Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J Neurol Neurosurg Psychiatry. 2018;89:1016–23.
   PubMed Web of Science ®Google Scholar
• Ngo ST, Mi JD, Henderson RD, McCombe PA, Steyn FJ. Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions. Degener Neurol Neuromuscul Dis. 2017; 7:95–108.
   PubMed Web of Science ®Google Scholar
• Holm T, Maier A, Wicks P, Lang D, Linke P, Munch C, et al. Severe loss of appetite in amyotrophic lateral sclerosis patients: online self-assessment study. Interact J Med Res. 2013;2:e8.
   PubMedGoogle Scholar
• Ahmed RM, Irish M, Piguet O, Halliday GM, Ittner LM, Farooqi S, et al. Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism. Lancet Neurol. 2016;15:332–42.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Ioannides ZA, Steyn FJ, Mi JD, Henderson RD, McCombe PA, Ngo ST. Predictions of resting energy expenditure in amyotrophic lateral sclerosis are greatly impacted by reductions in fat free mass. Cogent Med. 2017;4:1343000.
   Google Scholar
• Siri WE. Body composition from fluid spaces and density: analysis of methods. Techniques for measuring body composition. Washington, DC: National Academy of Sciences, National Research Council; 1961. p. 223–4.
   Google Scholar
• Roche JC, Rojas-Garcia R, Scott KM, Scotton W, Ellis CE, Burman R, et al. A proposed staging system for amyotrophic lateral sclerosis. Brain. 2012;135:847–52.
   PubMed Web of Science ®Google Scholar
• Wilson MM, Thomas DR, Rubenstein LZ, Chibnall JT, Anderson S, Baxi A, et al. Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr. 2005;82:1074–81.
   PubMed Web of Science ®Google Scholar
• Bates D, Mächler M, Bolker B, Walker S. Fitting linear mixed-effects models using 1me4. J Stat Soft. 2015;67:1–48.
   Web of Science ®Google Scholar
• Moglia C, Calvo A, Grassano M, Canosa A, Manera U, D'Ovidio F, et al. Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort. J Neurol Neurosurg Psychiatry. 2019;90:666–673.
   PubMed Web of Science ®Google Scholar
• van Eijk RPA, Eijkemans MJC, Ferguson TA, Nikolakopoulos S, Veldink JH, van den Berg LH. Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials. J Neurol Neurosurg Psychiatry. 2018;89:156–61.
   PubMed Web of Science ®Google Scholar
• Ngo ST, Steyn FJ, Huang L, Mantovani S, Pfluger CMM, Woodruff TM, et al. Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2015;357:22–7.
   PubMed Web of Science ®Google Scholar
• Vercruysse P, Sinniger J, El Oussini H, Scekic-Zahirovic J, Dieterle S, Dengler R, et al. Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis. Brain. 2016;139:1106–22.
   PubMed Web of Science ®Google Scholar
• Hillemacher T, Gräßel E, Tigges S, Bleich S, Neundörfer B, Kornhuber J, et al. Depression and bulbar involvement in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5:245–9.
   PubMed Web of Science ®Google Scholar
• Ahmed RM, Irish M, Henning E, Dermody N, Bartley L, Kiernan MC, et al. Assessment of eating behavior disturbance and associated neural networks in frontotemporal dementia. JAMA Neurol. 2016;73:282–90.
   PubMed Web of Science ®Google Scholar
• Crockford C, Newton J, Lonergan K, Chiwera T, Booth T, Chandran S, et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology. 2018;91:e1370–e80.
   PubMed Web of Science ®Google Scholar
• Ahmed RM, Dupuis L, Kiernan MC. Paradox of amyotrophic lateral sclerosis and energy metabolism. J Neurol Neurosurg Psychiatry. 2018;89:1013–1014.
   PubMed Web of Science ®Google Scholar
• Gorges M, Vercruysse P, Muller HP, Huppertz HJ, Rosenbohm A, Nagel G, et al. Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2017;88:1033–41.
   PubMed Web of Science ®Google Scholar
• McCombe PA, Ngo ST, Guo CC, Fazlollahi A, Bollmann S, Wang L, et al. Patient with ALS with a novel TBK1 mutation, widespread brain involvement, behaviour changes and metabolic dysfunction. J Neurol Neurosurg Psychiatry. 2018. Published Online First: 08 September 2018. doi: 10.1136/jnnp-2018-318823.
   Web of Science ®Google Scholar
• Ioannides ZA, Steyn FJ, Henderson RD, McCombe PA, Ngo ST. Anthropometric measures are not accurate predictors of fat mass in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:486–491.
   PubMed Web of Science ®Google Scholar
• Burgos R, Breton I, Cereda E, Desport JC, Dziewas R, Genton L, et al. ESPEN guideline clinical nutrition in neurology. Clin Nutr. 2018;37:354–96.
   PubMed Web of Science ®Google Scholar